Loading provider…
Loading provider…
Medical Oncology Physician in Cortlandt Manor, NY
NPI: 1295833937Primary Practice Location
HUDSON VALLEY HOSPITAL CENTER
1980 Crompond Rd, Cortlandt Manor, NY
Primary Employer
Option Care
optioncarehealth.com
HQ Phone
Get MD Mark's Phone NumberMobile
Get MD Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Zucker School of Medicine at Hofstra/Northwell
Residency • Internal Medicine
1975 - 1978
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 85 | 418 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 46 | 107 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 36 | 137 |
| 4 | 36415Insertion of needle into vein for collection of blood sample | 35 | 241 |
Characteristics and outcomes of lung cancer in solid organ transplant recipients.
Authors: Selim Arcasoy, Bryan Stanifer, William Bulman, Luke Benvenuto, Lanyi Chen, Matthen Mathew, Naiyer Rizvi, Catherine Shu
Journal: Lung Cancer
Publication Date: 2020-06-20
Authors: William Bulman, Naiyer Rizvi, Catherine Shu, Joshua Sonett
Journal: Cancer Cytopathol
Publication Date: 2017-10-12
Comparative effects of intravenously administered alizapride and prochlorperazine in cisplatin-induced emesis.
Authors: Roché, H., Hyman, G., Nahas, G., Stoopler, M., Ellison, R., Desjardins, R.
Lead Sponsor: Columbia University
Collaborators: Genentech, Inc., Celgene Corporation
Intervention / Treatment: DRUG: Carboplatin, DRUG: Nab-paclitaxel, DRUG: MPDL3280A
Lead Sponsor: Columbia University
Collaborators: Merck Sharp & Dohme LLC, National Cancer Institute (NCI), Massachusetts General Hospital
Intervention / Treatment: DRUG: Carboplatin, DRUG: Pembrolizumab, DRUG: Nab-paclitaxel, DRUG: Pemetrexed